Hypothesis

The aging brain selectively evicts hypoactive neurons not merely as an energy‑saving pruning process but because declining mitochondrial output pushes neuronal activity below a survival threshold, triggering activity‑dependent elimination. Restoring mitochondrial biogenesis in vulnerable excitatory neurons will raise their basal firing rates into the longevity‑promoting "Goldilocks zone" without causing pathological hyperactivity, thereby preventing eviction, preserving cognitive function, and extending lifespan.

Mechanistic Rationale

• Neuronal survival depends on maintaining activity above a set point; hypoactive cells are eliminated via activity‑dependent mechanisms [activity-dependent survival mechanism]
• Mitochondrial dysfunction reduces ATP, diminishing Na+/K+ pump efficiency and lowering spontaneous firing rates, especially in high‑energy wakefulness neurons [overactive wakefulness neurons disrupt sleep] (though the link is to hyperactivity, the underlying ion‑channel deficits illustrate how energy state shapes excitability)
• PGC‑1α drives mitochondrial biogenesis and enhances oxidative phosphorylation, increasing cellular ATP supply [mitochondrial biogenesis and neuronal activity] (NPAS4:NuA4 complex links activity to DNA repair, implying that higher activity improves genome stability)
• Elevating ATP restores KCNQ2‑mediated potassium currents, stabilizing excitability and preventing the shift toward hyperactivity that shortens lifespan [neural hyperactivity shortens lifespan]
• Combined, PGC‑1α‑driven mitochondrial uplift plus KCNQ2‑mediated conductance tuning should keep neuronal firing within the narrow window that supports both survival and longevity

Experimental Design

Subjects: 20‑month‑old C57BL/6J mice (both sexes) Groups (n=15 per group):

1. AAV‑Control (GFP)
2. AAV‑PGC‑1α (neuronal promoter Synapsin‑1)
3. AAV‑KCNQ2
4. AAV‑PGC‑1α + AAV‑KCNQ2 (co‑packaged or separate vectors) Delivery: Bilateral intracerebroventricular injection of engineered AAV2‑M1 for high neuronal transduction [engineered AAV2-M1]; verify >30% neuronal transduction, minimal glial off‑target Readouts (8 weeks post‑injection):

• In vivo two‑photon calcium imaging of layer 2/3 pyramidal neurons to quantify baseline firing rates and variability
• Immunohistochemistry for NeuN and active caspase‑3 to assess neuronal loss and eviction of hypoactive (low‑c‑Fos) cells
• Electroencephalography (EEG) to detect seizure‑like activity; power spectrum analysis to ensure no excess high‑frequency oscillations
• Cognitive battery: Morris water maze, novel object recognition
• Lifespan monitoring: record survival until natural death; calculate median lifespan and Gompertz mortality rate
• Mitochondrial function: ex vivo Seahorse assay on isolated cortical synaptosomes for basal and maximal respiration

Predicted Outcomes

• Mice receiving PGC‑1α alone will show modest ↑ ATP and ↑ firing rates, but a subset may drift into hyperactivity, reflected in increased EEG gamma power
• KCNQ2 alone will dampen excitability, potentially lowering firing below the survival threshold in already hypoactive cells, worsening eviction
• The combined PGC‑1α + KCNQ2 group is expected to:
  • Restore firing rates to the youthful range (≈1‑2 Hz baseline) without elevating gamma power >20 % over controls
  • Reduce caspase‑3+ hypoactive neurons by ~40 % relative to control
  • Improve spatial and recognition memory scores by ~25 %
  • Extend median lifespan by ~15 % and lower Gompertz slope, indicating slowed aging
  • Elevate basal respiration and spare respiratory capacity in synaptosomes

Potential Pitfalls & Alternatives

• Over‑expression of PGC‑1α could cause oxidative stress; include antioxidant response element reporter to monitor ROS
• AAV2‑M1 may still transduce periventricular glia; use Cre‑dependent vectors in CamKII‑Cre mice to restrict to excitatory neurons if needed
• If combined therapy fails to improve lifespan, the hypothesis that mitochondrial deficit drives activity‑dependent eviction would be falsified, suggesting alternative mechanisms (e.g., microglial pruning) dominate

This framework directly tests whether boosting neuronal energy supply can reset the activity set‑point that governs the brain’s selective eviction of neurons, distinguishing a programmed optimization from a maladaptive energetic failure